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ABSTRACT
Social anxiety disorder (SAD) is a debilitating condition, and it is estimated that
approximately half of adults who stutter have SAD. Thus, there is a need for the assessment and
treatment of SAD in this population. Cognitive-behavioral therapy (CBT) has shown promise in
decreasing anxiety symptoms among adults who stutter and have SAD, but exposure, the key
ingredient for successful CBT for SAD, has been understudied and underemphasized. The aims
of this study were to develop an exposure therapy protocol specifically for people who stutter
and have SAD and to evaluate its efficacy for reducing anxiety and stuttering severity. Utilizing
a multiple baseline design, six participants were randomized to receive zero, two, or four
sessions of progressive muscle relaxation therapy. This served to establish the staggered start and
to account for the common factors of therapy. All participants received ten sessions of exposure
therapy. Participants recorded daily social anxiety levels, and anxiety and stuttering severity
were assessed at major assessment points. All participants demonstrated substantial reductions in
social anxiety and substantial improvements in the affective, behavioral, and cognitive
experiences of stuttering following exposure therapy. No reliable change was observed for
stuttering frequency. Results suggest that exposure therapy may be useful for people who stutter
and have SAD, but will not necessarily influence their speech fluency. These findings underscore
the importance of the assessment and treatment of SAD among adults who stutter and suggest
that the integration of care between psychologists and speech-language pathologists may prove
beneficial for this population.
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CHAPTER 1: INTRODUCTION
1.1

Social Anxiety Disorder

Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder
characterized by fear of social judgment. Situations that individuals with SAD may fear, avoid,
and/or endure with distress include social interactions, being observed, and performing in front
of others. In particular, individuals with SAD fear that they will be negatively evaluated. With a
lifetime prevalence of approximately 12%, SAD is one of the most prevalent lifetime mental
disorders, following only major depressive disorder, alcohol abuse, and specific phobia (Kessler
et al., 2005).
SAD is a serious, debilitating condition. The impairment and the associated reduced
quality of life are substantial (Stein & Kean, 2000). Individuals with SAD experience more
scholastic difficulties, dysfunction in daily activities, and problems related to interpersonal
relationships (Stein & Kean, 2000). Quality of life for individuals with SAD is influenced by
reduced satisfaction with leisure and daily activities, family life, friends, and income (Stein &
Kean, 2000). Additional negative outcomes associated with SAD include increased cannabis and
alcohol dependence (Buckner et al., 2008) and additional psychiatric disorders, especially other
anxiety disorders and depression (Schneier, Johnson, Hornig, Liebowitz, & Weissman, 1992).
When SAD is comorbid with other psychiatric disorders, it is associated with increased financial
dependence and an increased number of suicide attempts (Schneier et al., 1992).
Due to the discomfort of social interactions, many individuals with SAD tend to engage
in avoidant behavior, which may include overt or subtle avoidance. Simply avoiding social
situations constitutes overt avoidance. Subtle avoidance may involve the individuals with SAD
1

focusing on themselves rather than the situation (Bögels & Mansell, 2004), mentally distancing
themselves from the feared situation (Rodebaugh, Holaway, & Heimberg, 2004), or the use of
safety behaviors (Wells et al., 1995). Safety behaviors in SAD are performed in an effort to
reduce the likelihood of negative social evaluation. For example, researchers identified safety
behaviors such as speaking quickly, taking deep breaths, rehearsing sentences, and avoiding eye
contact in a participant with SAD who feared talking to a group of strangers (Wells et al., 1995).
While the intention of engaging in safety behaviors is to avert fears, like other methods of
avoidance, safety behaviors are problematic because they actually contribute to the maintenance
and exacerbation of fear (Helbig‐Lang & Petermann, 2010; Wells et al., 1995). Engaging in
safety behaviors prevents full exposure to the feared event. Safety behaviors may prevent
individuals from fully habituating to their feared event and/or from disconfirming their beliefs
that they will be negatively evaluated (Kim, 2005; Wells et al., 1995).

1.2

Stuttering

Stuttering is a communication disorder characterized by involuntary interruptions in the
forward flow of speech (Bloodstein & Bernstein Ratner, 2008). Most researchers and speechlanguage pathologists agree that stuttering consists of sound, syllable, or monosyllabic word
repetitions; oral or silent sound prolongations; and broken words. The current edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric
Association, APA, 2013) places stuttering, also called childhood-onset fluency disorder,
alongside other communication disorders in the neurodevelopmental disorders category. The
lifetime prevalence of stuttering is estimated to be approximately 4% - 5%, while at any given
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point in time, about 1% of the population stutters (Bloodstein & Bernstein Ratner, 2008). In
adulthood, males who stutter outnumber females who stutter four to one (Iverach, O'Brian, et al.,
2009).
Stuttering is a universal disorder which often presents prior to age three, but the age of
onset ranges from two to seven years (APA, 2013; Yairi & Ambrose, 1992), which largely
coincides with the speech and language developmental period. Onset can be gradual or rapid
(APA, 2013; Yairi & Ambrose, 1992). Although the cause of stuttering remains elusive,
neurological deficits are a likely component (Bloodstein & Bernstein Ratner, 2008; SmitsBandstra & Luc, 2007) and genetic factors are likely involved (Bloodstein & Bernstein Ratner,
2008; Domingues et al., 2014; Frigerio‐Domingues & Drayna, 2017).
While the majority of children who stutter naturally recover, stuttering develops into a
lifelong problem for a small but significant proportion of adults (APA, 2013; Onslow, 2004). By
disrupting speech production, stuttering impedes the ability to communicate effectively.
Communication through speech is important to social and occupational functioning and overall
quality of life (Iverach, O'Brian, et al., 2009). Thus, it is no surprise that stuttering is associated
with numerous negative outcomes throughout the lifespan. Children as young as three who
stutter are more likely to demonstrate impaired behavioral, emotional, and social development
compared to typically-developing children (McAllister, 2016). Stuttering has the potential to
elicit negative peer responses for children as young as three and four years old (Langevin,
Packman, & Onslow, 2009). Preschool and kindergarten children who stutter report a more
negative attitude about their speech than their nonstuttering peers (Vanryckeghem, Brutten, &
Hernandez, 2005). Children who stutter are more likely to be rejected by their peers (Davis,
3

Howell, & Cooke, 2002); they are less likely to be popular (Davis et al., 2002); and they are
often bullied (Blood & Blood, 2007). In adolescence, stuttering continues to be associated with
greater risk for bullying, and it is also associated with lower self-perceived communicative
competence (Blood & Blood, 2004). Adolescents who stutter who are at risk for bullying report
lower self-esteem (Blood & Blood, 2004). Adults who stutter are at increased risk for developing
social, psychological, and behavioral problems (Craig, 2003).
In general, people who stutter are likely to experience negative stereotypes and listener
reactions throughout their lives (Klompas & Ross, 2004; Snyder, 2001). These negative
experiences may lead to low self-esteem, withdrawal, and feelings of guilt, shame,
embarrassment, and frustration (Langevin & Prasad, 2012). It is understandable, then, that many
people who stutter develop negative attitudes toward speaking (Andrews & Cutler, 1974;
Erickson, 1969; Vanryckeghem & Brutten, 2011, 2012; Yaruss & Quesal, 2006). Similar to
many individuals with SAD, many adults who stutter fear, struggle with, and/or avoid situations
in which they have to speak, and they engage in overt and subtle avoidant behaviors as a means
of coping (Lowe et al., 2017; Plexico, Manning, & Levitt, 2009; Vanryckeghem & Brutten,
2011, 2012). Common subtle avoidant behaviors among people who stutter include substitution
or avoidance of difficult words (Plexico et al., 2009). Indeed, the definition of stuttering, in
addition to repetitions, prolongations, and blocking of sounds, often includes the substitution and
avoidance of words (Bloodstein & Bernstein Ratner, 2008).
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1.3

The Relationship between Social Anxiety and Stuttering

The role of anxiety in stuttering has been debated over the years. Many theorists have
speculated that anxiety might be causally linked to stuttering. Few people who stutter and few
speech-language pathologists would deny the role of anxiety and emotional reactivity in
stuttering. Recent research supports a neurological cause for stuttering, yet anxiety remains one
of the most common concomitants of stuttering (Menzies, Onslow, & Packman, 1999; SmitsBandstra & Luc, 2007).
The temporal relationship between anxiety and stuttering suggests that stuttering may
engender anxiety. In a review and analysis, Alm (2014) found that preschool children who
stuttered were neither shyer nor more socially anxious than peers who did not stutter; yet,
speech-related social anxiety develops in many cases of stuttering before adulthood. It has been
suggested that some people who stutter develop anxiety in adolescence (Smith et al., 2017), and
that the development of social anxiety may be due to continued negative experiences with
speaking (Menzies et al., 2008). Iverach, Lowe, et al. (2017) found that self-reported stuttering
severity predicted higher anxiety among adolescents who stutter. In a meta-analysis including
almost 1,300 adults, Craig and Tran (2014) found that the majority of adults who stutter have
moderately elevated trait anxiety and substantially elevated social anxiety. Considering the
inherent reliance on speaking in social interactions, elevated social anxiety among adults who
stutter is unsurprising. There is a growing body of evidence supporting the significant prevalence
of social anxiety among adults who stutter (Blood & Blood, 2016; Blumgart, Tran, & Craig,
2010).
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The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSMIV-TR; APA, 2000) precluded a diagnosis of SAD among individuals whose anxiety was related
to stuttering, presumably under the belief that elevated social anxiety was a reasonable reaction
to stuttering. Nonetheless, many researchers advocated for increased assessment and treatment of
anxiety among people who stutter (Iverach, O'Brian, et al., 2009; Menzies et al., 2008; Stein,
Baird, & Walker, 1996), noting the significant and problematic prevalence of social anxiety
symptoms. The most recent version of the DSM, the DSM-5, now allows for SAD to be
diagnosed in people who stutter, as long as the social fear, avoidance, or distress is either
unrelated or excessive to the stuttering (APA, 2013).
It is clear that the role of anxiety, especially social anxiety, in stuttering is not fully
understood, yet it is a serious problem for many adults who stutter. Hence, this matter merits
further research.

1.4

Clinical Implications

Among children who stutter, an estimated 20% develop chronic stuttering (Craig, 2000).
Among adults who stutter, an estimated 20% - 60% have significant social anxiety (Blumgart et
al., 2010; Iverach, O'Brian, et al., 2009; Kraaimaat, Vanryckeghem, & Van Dam-Baggen, 2002;
Menzies et al., 2008; Stein et al., 1996). In a study identifying the prevalence of anxiety
disorders among children who stutter, Iverach et al. (2016) found that children who stutter had a
six-fold increased odds for SAD compared to nonstuttering controls. In a study identifying the
prevalence of anxiety disorders among treatment-seeking adults who stutter, Iverach, O'Brian, et
al. (2009) found that adults who stutter had 16- to 34-fold increased odds of meeting criteria for
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SAD compared to matched controls. The authors suggested that the comorbid presence of
stuttering and significant anxiety might increase the likelihood that individuals who stutter will
seek treatment for their stuttering. Noting the historical absence of SAD diagnoses, the authors
elucidated the clinical implications of the exceptionally high prevalence of anxiety disorders
among adults who stutter – the assessment and treatment of anxiety disorders, especially SAD,
should be a critical priority among adults who stutter. It has been suggested that comprehensive
treatment for stuttering should address anxiety specifically (Blumgart, Tran, & Craig, 2014;
Craig, 1990; Iverach, Rapee, Wong, & Lowe, 2017), as targeted psychological assessment and
intervention may improve overall stuttering treatment (Iverach, Jones, et al., 2009). Recently,
researchers have advocated for the increased integration of care for adults who stutter between
speech-language pathologists and clinical psychologists (Iverach, O'Brian, et al., 2009; Iverach
& Rapee, 2014; Menzies et al., 2008).
Current treatment for stuttering typically uses fluency shaping, stuttering modification, or
an integration of both approaches. Fluency shaping aims to teach individuals who stutter to speak
more fluently. The goal is to learn and apply techniques that facilitate more fluent speech.
Fluency shaping often uses variations of prolonged speech, which focuses on speech rate
modification and fluency shaping strategies, such as easy onset, soft contact, and delayed
auditory feedback. Using these techniques, people who stutter are taught to slow their speech
rate, systematically reshape their speech toward more normal sounding speech, and generalize
their methods to use outside the clinic. While fluency shaping has proven to be effective at
reducing stuttering severity (Andrews, Guitar, & Howie, 1980), it largely ignores any role of
anxiety. Stuttering modification, on the other hand, typically utilizes a multidimensional
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approach that incorporates behavioral, affective, and cognitive components. Treatment is often
aimed at modifying neuro-motoric involvement in speech by employing techniques to decrease
the tension associated with stuttering behaviors, to facilitate desensitization to stuttering, and to
increase acceptance of stuttering (Blomgren, Roy, Callister, & Merrill, 2005). Common
components of the stuttering modification approach include preparatory set, cancellation, and
pull-out (Van Riper, 1982). As with fluency shaping, the ultimate goal is to generalize these
methods to use outside the clinic. Notably, while stuttering modification addresses anxiety, it
does not explicitly address the widespread social anxiety among people who stutter.
Current treatment for SAD typically uses a form of cognitive-behavioral therapy (CBT),
which has the greatest empirical support in the treatment of SAD (Rodebaugh et al., 2004). CBT
can be considered a general term that incorporates a number of various techniques in varying
combinations, such as exposure, applied relaxation, social skills trainings, and cognitive
restructuring. However, exposure can be considered the essential component for successful
treatment of SAD (Rodebaugh et al., 2004). In exposure therapy, the individual confronts his or
her feared situations in a controlled manner. In SAD, the feared situations are social encounters
in which the individual would be exposed to potential negative evaluation by others. The
effectiveness of exposure in the treatment of SAD is supported in two separate meta-analytic
reviews (Feske & Chambless, 1995; Gould, Buckminster, Pollack, & Otto, 1997).
In an experimental clinical trial of a CBT package for adults who stutter, Menzies et al.
(2008) randomized 30 adults who stutter (60% of whom were diagnosed with comorbid SAD)
into two groups. One group received a speech restructuring treatment program, which consisted
of procedures designed to control stuttered speech. Participants in this group learned to produce
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prolonged speech at a slower rate, and they practiced the new speech pattern. The speech
restructuring treatment program was deliberately stripped of any activities that related to
cognitive and/or behavioral intervention that would overlap with CBT. The other group received
CBT in addition to the speech restructuring treatment. The CBT package consisted of ten weekly
sessions that incorporated cognitive restructuring, graded exposure, and behavioral experiments.
In cognitive restructuring, the participants systematically identified and modified their irrational
thoughts; in graded exposure, they gradually and progressively confronted their feared situations;
and in the behavioral experiments, they compared predicted negative outcomes to actual
outcomes of exposure exercises. The group that received CBT and speech restructuring treatment
had superior and sustained measures of improved psychological functioning compared to the
group that received speech restructuring treatment only. The groups did not significantly differ in
stuttering severity following treatment. Some of the gains in psychological functioning were
apparent after the experimental group completed CBT, before they began the speech
restructuring treatment, which lends support for the effectiveness of isolated CBT for people who
stutter. More recently, Helgadóttir, Menzies, Onslow, Packman, and O’Brian (2014) developed a
standalone internet treatment based on the same CBT package and found similar results –
significant post-treatment improvements in psychological functioning, but no significant changes
in stuttering frequency. In 2016, they developed a fully automated version of the treatment and
again found similar results – treatment completion was associated with significant improvements
in self-reported psychological functioning. This study did not measure stuttering severity
(Menzies, O’Brian, Lowe, Packman, & Onslow, 2016). While the CBT package used in these
studies is consistent with other commonly used CBT packages, it borrows heavily from the
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cognitive model of social anxiety – it neither emphasizes nor isolates the effectiveness of
exposure, the key ingredient of CBT and gold standard treatment for SAD.
Other researchers have reported positive outcomes from CBT with adults who stutter in
both psychological functioning and speech fluency (Gupta, 2016; Gupta, Yashodharakumar, &
Vasudha, 2016; Reddy, Sharma, & Shivashankar, 2010). However, they incorporated traditional
speech-therapy techniques into their therapeutic programs. Thus, the isolated role of CBT is
indeterminate. Similar to the other studies, they also emphasized a cognitive approach (e.g.,
relaxation techniques, cognitive restructuring), and thus underemphasized the role of exposure.
Walkom (2016) developed and piloted a program of exposure therapy via virtual reality
for people who stutter. Several adults who stutter engaged in two separate exposure tasks lasting
5 minutes each that consisted of speaking in front of a virtual audience. Detailed outcome data
were not reported, but the author concluded that the intervention showed promise in reducing
anxiety and improving speech fluency among people who stutter and have social anxiety.
No previous studies have rigorously investigated the isolated effectiveness of exposure
therapy for people who stutter and have SAD. Therefore, the aim of this research study was to
develop an exposure therapy protocol for this population and evaluate its efficacy in reducing
anxiety and stuttering severity. Individuals who stutter are often anxious about speaking in front
of others. More specifically, they are commonly fearful of pronouncing their name disfluently;
they often substitute or avoid certain sounds and words that are associated with their stuttering
behavior; and they vary in their level of anxiety surrounding extemporaneous speech versus
reading aloud. Hence, the exposure task incorporated all of these situations. A multiple baseline
across participants design was utilized to test the intervention in a cost- and time-effective

10

manner. As is common in multiple baseline design research, repeated measures were recorded
during baseline and intervention phases. This study added a psychological placebo intervention
prior to the proposed active intervention to account for the common factors of therapy, to provide
additional support for the effectiveness of exposure therapy. It was hypothesized that social
anxiety levels would remain stable during the baseline phase, reduce slightly during the
psychological placebo intervention, decrease gradually and substantially during the exposure
intervention, and remain low at the post-assessment. Social, state, and trait anxiety were assessed
at major assessment points to further evaluate change. Social and state anxiety were expected to
reduce after the exposure intervention. No change was expected for trait anxiety. To evaluate
change stuttering severity, stuttering frequency and the affective, behavioral, and cognitive
experiences of stuttering were also assessed at major assessment points, and they were expected
to improve only after the exposure intervention. Finally, participants’ response to exposure
therapy was examined.

11

CHAPTER 2: METHODS
2.1

Participants

Participants consisted of six individuals recruited from Central Florida. Inclusion criteria
were: (a) at least 17 years of age; (b) English language proficiency; (c) met criteria for SAD, as
defined by DSM-5 (confirmed via administration of Anxiety and Related Disorders Interview
Schedule for DSM-5 [ADIS-5] - Adult Version); (d) if met criteria for another DSM-5 defined
clinical disorder, SAD was determined to be primary (excluding childhood onset-fluency
disorder [stuttering]); (e) onset of stuttering in early developmental period, not attributable to
neurological insult or other medical condition; (f) stuttering frequency ≥ 3% of words spoken
during reading or extemporaneous speech; and (g) if taking psychotropic medications, dose must
be stabilized for at least two weeks. Exclusion criteria were: (a) elevated risk requiring a higher
level of care, including current suicidal/homicidal intent, psychosis, or substance use disorder;
(b) suspected intellectual developmental disorders, autism spectrum disorders, or comorbid
communication disorders; (c) concurrent enrollment in psychotherapy or speech therapy; and (d)
previous course of exposure-based therapy for social anxiety.
Of note, towards the end of treatment, one of the participants (P6) revealed that they were
concurrently enrolled in a program at their school based to their speech, but they were unsure if it
was considered speech therapy. The program entailed meeting with an instructor at the school
(unclear if this was a speech-language pathologist) and a peer with a different speech problem
(diagnosis unknown) for approximately 0.5 hours per week. The participant reported that the
sessions consisted of taking turns reading aloud with the peer. Due to the relatively low dose of
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treatment and the absence of identifiable fluency shaping or stuttering modification techniques,
this participant was included in the final analysis.
Participant ages were 17, 19, 30, 31, 40 and 43; three were females and three were males;
three were Caucasian, two were Hispanic, and one was Asian; two participants were married and
four were single; highest level of education ranged from high school to university degrees; and
employment included student, truck loader/unloader, financial services/risk management
specialist, and computer engineer.

2.2

Study Design

This study utilized a randomized, nonconcurrent, multiple baseline across participants
design (Barlow, Nock, & Hersen, 2009). All participants recorded at least seven days of baseline
(BL) data, then they were randomized to receive zero, two, or four sessions of progressive
muscle relaxation therapy (PMR). PMR has demonstrated minimal effects when used as an
isolated intervention and has successfully served as a control condition in SAD treatment
outcome studies (Rodebaugh et al., 2004). Thus, PMR served to establish the staggered start and
to control for the common factors of therapy, which is the aim of a psychological placebo.
During the subsequent exposure therapy (EXP) phase, all participants received ten sessions of
individual EXP, two to three sessions per week. Of note, one of the participants (P3) elected to
take an approximately one-month break from treatment between EXP sessions 6 and 7, citing
unexpected work and family responsibilities. Due to the relative continuity of treatment gains,
despite this gap, this participant was included in the final analysis. Throughout enrollment in the
treatment program, participants recorded a daily rating of social anxiety. Additionally, all
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participants completed a battery of assessments at major assessment points: BL, post-PMR, and
post-EXP.
The multiple baseline design allows for observation of symptom change over time. If
symptoms change when and only when a new intervention is introduced, this allows for a causal
inference about the effectiveness of the intervention. This study presents a unique adaptation of
the multiple baseline design in that it utilizes a psychological placebo condition (PMR) to control
for common factors of therapy before presenting the proposed active intervention (EXP). If the
EXP leads to a reduction in symptoms above and beyond that of PMR, this will provide
substantial support for the unique effectiveness of EXP. The use of a single case design is further
justified due to the overall low base rate of the comorbid presentation of stuttering and SAD.

2.3

Procedures

Participants were recruited from the community via flyers posted at the University of
Central Florida (UCF) Psychology Clinic and the UCF Communications Disorders Clinic and
emails sent to members of an organization that supports people who stutter. Interested
individuals who appeared to be eligible for the study were scheduled for part one of a two-part
in-person assessment. In part one, a member of the research team provided an overview of the
study, its purpose, and a brief description of the treatment and obtained informed consent.
Participants were administered self-report questionnaires and speech samples were collected and
recorded. Speech samples were independently transcribed and analyzed by two trained members
of the research team, discrepancies were settled by consensus. The speech samples were
reviewed by the master coder, a board certified fluency specialist, who confirmed the percentage
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of words stuttered (%WS). Participants whose %WS was ≥ 3% during either reading or
extemporaneous speech were scheduled for part two. In part two, participants were administered
a clinical interview and additional self-report questionnaires. Participants who met diagnostic
criteria for SAD and none of the exclusion criteria were eligible for continued participation in the
study. Treatment was offered at no cost.
The participants completed all self-report questionnaires with the assistance of a member
of the research team. All assessment and treatment was conducted at the UCF Psychology Clinic
by a clinical psychology doctoral student (the author), under the supervision of a licensed clinical
psychologist. All procedures were approved by the University of Central Florida Institutional
Review Board.
Participant flow is presented in Figure 1. Since participants serve as their own controls,
noncompleters do not have sufficient data to be included in the analyses. Thus, recruitment
remained open until six participants completed the post-EXP assessment. Only one participant
began the treatment and subsequently dropped-out. The participant accepted an out-of-state job
offer. There were no discernable differences between completers and the one noncompleter in
regards to demographics or symptom presentation.
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Figure 2-1: Participant Flow Chart

2.4
2.4.1

Measures
Primary

2.4.1.1 Anxiety
Throughout the BL, PMR, and EXP phases of the study, participants were provided with
a Daily Behavioral Ratings (DBR) form, in which they monitored the frequency and severity of
social- and speaking-related symptoms each day, such as overall social anxiety and avoided
speaking situations. (See Appendix A.) The daily rating of overall social anxiety served as the
main outcome for this study. Participants were asked to rate their social anxiety (0 – 10) each
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day. Specifically, they were instructed: “Think over your whole day. How would you rate your
overall anxiety due to social interactions or the possibility of social interactions?”
The Social Phobia and Anxiety Inventory (SPAI; Beidel, Turner, Stanley, & Dancu,
1989; Turner, Beidel, Dancu, & Stanley, 1989) and the State-Trait Anxiety Inventory (STAI)
Form-Y (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) were administered at major
assessment points to further assess anxiety. The SPAI assesses the range and severity of social
fears as well as the somatic, cognitive, and behavioral aspects of SAD. The SPAI has high testretest reliability (r = .86), good concurrent and external validity, and differentiates patients with
SAD from normal controls or patients with other anxiety disorders. The STAI is a widely used
measure for state and trait anxiety. It has demonstrated good psychometric properties
(Spielberger et al., 1983).
Presence of SAD and other clinical disorders were assessed via the Anxiety and Related
Disorders Interview Schedule for DSM-5 (ADIS-5) - Adult Version (Brown & Barlow, 2013,
2014), a semi-structured interview designed to diagnose anxiety and related disorders. It is the
gold standard for the diagnosis of anxiety disorders and has well-established reliability and
validity. All of the clinical interviews were audio and video recorded. Three recordings (25% of
the total recordings) were randomly selected and viewed by an independent and blinded rater,
also a clinical psychology doctoral student. Diagnostic agreement was 100%.

2.4.1.2 Stuttering Severity
Stuttering frequency was assessed at major assessment points via speech samples.
Participants were audio and video recorded speaking in three contexts: reading, monologue, and

17

conversation. The speech samples were all collected in this order. For the reading sample,
participants were provided with one of two 300-word scripts that were matched for reading level
(Brutten, 1957). For the monologue sample, participants were asked to describe a series of 16
photos, presented in a random order, until they had spoken approximately 300 words. For the
conversation sample, participants were asked to engage in conversation with the assessor on a
series of topics until they had spoken approximately 300 words. The speech samples were
independently transcribed and coded by two research assistants trained to identify stuttering
behaviors. Each word containing a stuttering behavior (sound, syllable, or monosyllabic word
repetition; oral or silent sound prolongation; or broken word) was counted as a stuttered word.
Percentage of words stuttered (%WS) was calculated in relation to the total number of words
spoken. Discrepancies were agreed on by consensus. The master coder reviewed all BL samples,
the first 150 words for each post-PMR sample, and all post-EXP samples. Research assistant
consensus matched the master coder at an accuracy rate of 96.48%.
The affective, behavioral, and cognitive experiences of stuttering were measured using
the Behavioral Assessment Battery for Adults (BAB; Brutten, 1973, 1975; Vanryckeghem, 1999;
Vanryckeghem & Brutten, in press). The BAB is a collection of self-report measures that assess
affective, behavioral, and cognitive accounts of people who stutter. A modified version of the
Fear Survey Schedule II (FSS-II; Geer, 1965), which is commonly included with the BAB, was
also administered. The BAB is composed of the Speech Situation Checklist, the Behavior
Checklist, and the Communication Attitude Test for Adults. These measures have been
investigated internationally, have been shown to be reliable and valid, and can differentiate
people who stutter from people who do not stutter. The Speech Situation Checklist (Bakker,
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1995; Bakker & Brutten, 1982; Brutten, 1973, 1975; Brutten & Janssen, 1981) has two
components. The Speech Situation Checklist - Emotional Reaction (SSC – ER) assesses negative
emotional reaction, such as anxiety, concern, and worry, in speech situations (e.g., “talking on
the telephone,” “giving directions,” “talking with teachers or supervisors”). The Speech Situation
Checklist - Speech Disruption (SSC – SD) assesses speech disruption, described as getting stuck
on, repeating, or prolonging sounds or words, in the same speech situations. In each component,
the 38 speech situations are rated on a 5-point scale (1 = not at all to 5 = very much). The SSC
has been shown to have high internal reliability (r = .95 and higher) and good content validity.
The Behavior Checklist (BCL; Vanryckeghem, Brutten, Uddin, & Van Borsel, 2004) currently
lists 60 behaviors (the original test had 95 items) that may be used as a means to escape or avoid
a stutter (e.g., “touch or ruffle your hair,” “clear your throat,” “tap your foot/feet”). These
behaviors are considered secondary to the stuttering. The rater is asked to indicate whether he or
she engages in certain behaviors to help get sounds or words out, by indicating “yes” or “no” to
each item. Items marked “yes” are rated on a 5-point scale relative to the frequency with which
they are being used (1 = very infrequently to 5 = very frequently). The BCL has good internal
reliability and validity, and it can reliably distinguish between people who stutter and people
who do not stutter. The Communication Attitude Test for Adults (BigCAT; Vanryckeghem &
Brutten, 2011, 2012; Vanryckeghem & Muir, 2016) is a 34-item true-false measure designed to
assess speech-associated cognition (e.g., “There is something wrong with the way I speak,”
“Speaking is no problem for me”). It has been shown to have good internal consistency for
people who stutter (α = .84) and can reliably distinguish between people who stutter and people
who do not stutter (Vanryckeghem & Brutten, 2011, 2012). Additionally, it has demonstrated

19

good test-retest reliability (r = .80) (Vanryckeghem & Muir, 2016). The FSS-II (Geer, 1965) is a
51-item measure that lists objects and situations which may cause fear or discomfort (e.g., “sharp
objects,” “worms,” “being criticized”). Internal consistency reliability has been found to be high.
The FSS-II, which was originally on a 7-point scale, has been modified to be rated on a 5-point
scale (from “not at all afraid” to “very much afraid”) to maintain consistency with SSC measures
(Brutten, 1973). Participants completed the BAB and the FSS-II in this order: FSS-II, SSC - ER,
BCL, BigCAT, SSC - SD.

2.4.2

Secondary

The Quality of Life Inventory (QOLI; Frisch, 1994) was administered to measure wellbeing and life satisfaction. The QOLI is a brief psychological assessment that presents 16 life
areas and asks respondents to rate how important (3-point rating scale) and how satisfied (6-point
rating scale) they are with each area. It has been extensively evaluated and has demonstrated
sound psychometric properties (Frisch, Cornell, Villanueva, & Retzlaff, 1992). The QOLI was
administered at BL and post-EXP.
The subjective and objective experience with EXP among the participants was an
important exploratory area of interest in this research study. The credibility/expectancy
questionnaire (Devilly & Borkovec, 2000) is a measure of treatment expectancy and rationale
credibility specifically designed for use in outcome research. It has high internal consistency
within each factor (credibility and expectancy) and good test-retest reliability. Participants
completed this measure after two sessions of EXP. Between-sessions measures of anxiety and
stuttering severity were assessed during the EXP phase. The Subjective Units of Distress (SUDs)
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Scale is commonly used during exposure tasks in cognitive-behavioral therapy (CBT) for
anxiety. Participants reported their SUDs on a 9-point scale (0 = no anxiety to 8 = extreme
anxiety) at five-minute intervals. EXP sessions were transcribed and coded by research assistants
trained to identify stuttering behaviors, so that %WS per five-minute interval could be
calculated. Peak SUDs and peak %WS were evaluated for sessions 1, 5, and 10.
Raters blind to session number viewed recordings of the first 20 minutes of each EXP
session and rated the speaker on three components: level of anxiety (1 = none to 5 = very severe),
level of stuttering (1 = none to 5 = very severe), and overall effectiveness of the presentation (1 =
not at all to 5 = extremely) (see Appendix B). Indices of low levels of anxiety included frequent
eye contact, appropriate volume of speech, occasional spontaneous speech, relaxed posture, open
body position, and natural body movement. Indices of high levels of anxiety included minimal
eye contact, low voice, lack of spontaneous speech, tense/frozen posture, hiding behind
furniture/props, and excessive gross motor movements (hand wringing, leg shaking, fidgeting).
Indices of low levels of stuttering included minimal identifiable stutters and minimal disruption
to speech. Indices of high levels of stuttering included frequent stuttering and very disruptive to
speech. Indices of low levels of overall effectiveness included looks awkward, unengaging, and
appears uncomfortable. Indices of high levels of overall effectiveness included looks natural,
engaging, and appears to enjoy presenting. Twelve sessions (20% of the sessions) were selected
to determine inter-rater reliability. Overall, there was moderate agreement on the ratings (ICC =
.725). Further examination of agreement by component demonstrated moderate agreement for
ratings of anxiety (ICC = .567) and effectiveness (ICC = .731), and good agreement for ratings
of stuttering (ICC = .820).

21

2.5
2.5.1

Intervention

Progressive Muscle Relaxation Therapy (PMR)

Participants were randomly assigned to receive zero, two, or four sessions of PMR. The
PMR sessions were conducted individually and in-person, and they consisted of a guided
progressive muscle relaxation exercise. The participants were instructed to relax, close their
eyes, and focus on their breathing. Then, they were asked to tense various muscles in their body
as they breathed in deeply, and then gently release the muscles as they breathed out fully. The
exercise progressed through the major muscles in the body, beginning with the feet and ending
with the face muscles. The therapist provided the participants with an opportunity to ask
questions and address concerns about their anxiety and speech. Each session lasted
approximately 50 minutes.

2.5.2

Exposure Therapy (EXP)

The EXP sessions were also conducted individually and in-person. All participants
engaged in ten EXP sessions. At the beginning of each session, participants were provided with
the script of the speech they would be presenting that day. Participants were provided with a
different script each session. All participants received the same scripts in the same order.
Participants were given ten minutes to review and prepare, and then they presented the speech in
front of an audience of between three and six adults. Participants were asked to introduce
themselves and their topic, present the speech, and deliver an impromptu response to a prompt
related to the speech topic. This process (provide introduction, deliver speech, answer prompt)
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was repeated as many times as was necessary until the session was ended. A unique prompt was
provided each time.
According to emotional processing theory, which aims to identify the mechanisms of
action in EXP, an exposure task requires fear activation, within-session habituation, and
between-session habituation in order to be successful in reducing fear and anxiety (Foa & Kozak,
1986). To achieve fear activation, common fears among people who stutter were incorporated
into the exposure task. First and foremost, individuals who stutter are commonly anxious about
speaking in front of others, thus the exposure task consisted of speaking in front of a small
audience. Individuals who stutter are commonly fearful of pronouncing their name disfluently,
thus the exposure task required the participants to introduce themselves at the beginning of each
speech. Individuals who stutter often substitute or avoid certain sounds and words that are
associated with their stuttering behavior, thus each script incorporated all potential anxietyprovoking sounds (i.e., each of the ten scripts contained at least one word that started with each
letter of the English alphabet). Participants were instructed to state aloud all of the words from
the script (although, they were free to elaborate). Individuals who stutter vary in their level of
anxiety associated with reading aloud and extemporaneous speech production, thus the exposure
task required participants to both read aloud from the provided script and deliver impromptu
responses to prompts and questions. The audience members were encouraged to ask the
participant questions throughout the exposure task. To ensure within-session habituation, the
participants were asked to provide their SUDs at 5-minute intervals, and the exposure task was
not ended until the participant reported that their SUDs was at least half that of their peak SUDs
in that session, or overall distress was low (participant reported zeros or ones). (Between-session
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habituation is not something that can be initially designed as part of the exposure, rather
something that indicates progress over time.)
Rationale credibility and treatment expectancy for EXP were examined, based on ratings
on the credibility/expectancy questionnaire (Devilly & Borkovec, 2000). All participants found
EXP to be highly logical (M = 8.17, SD = 0.75, range 7 to 9) and would be confident in
recommending the treatment to a friend (M = 8.00, SD = 0.89, range 7 to 9). Participants were
asked to rate how they thought and how they felt about EXP. All participants thought EXP would
be successful in reducing their symptoms (M = 7.17, SD = 1.17, range 6 to 9). Four participants
thought there would be 70% - 80% improvement and two participants thought there would be
30% - 40% improvement in symptoms (M = 0.60, SD = 0.20, range 30% to 80%). All
participants reported that they felt that EXP would reduce their symptoms (M = 6.50, SD = 1.05,
range 5 to 8). Three participants felt there would be 70% improvement and three participants felt
there would be 30% - 60% improvement in symptoms (M = 0.58, SD = 0.16, range 30% to 70%).
Overall, the participants reported high credibility and expectancy for EXP.

2.6

Data Analysis

Data analysis was conducted in a manner consistent with that of a multiple baseline
design (Barlow et al., 2009). However, this study included a psychological placebo (PMR) to
establish the staggered start, which is traditionally accomplished by manipulating the length of
the baseline. Change due to common factors of therapy should be captured in the PMR phase,
thus changes that are apparent only after the active intervention (EXP), can be more confidently
attributed to the proposed active ingredients of EXP. Each participant recorded daily ratings of
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social anxiety during each phase (BL, PMR, and EXP). The daily ratings of social anxiety were
graphed over time, and the level and slope of the ratings for each phase were compared via visual
inspection.
Descriptive statistics were calculated for all of the measures administered at major
assessment points: BL, post-PMR, and post-EXP. These data provide additional information
about the magnitude of change attributable to PMR and EXP. Data from EXP sessions (peak
SUDS; peak %WS; and the blinded observer ratings of anxiety, stuttering, and overall
effectiveness) provide information about the subjective and objective changes between sessions
of EXP.
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CHAPTER 3: RESULTS
3.1
3.1.1

Primary
Anxiety

Figure 3-1 displays social anxiety ratings during baseline (BL), psychological placebo
(progressive muscle relaxation therapy; PMR), active intervention (exposure therapy; EXP), and
the post-assessment (POST). BL data points represent the first seven days that the participants
began recording daily social anxiety. Data points in the subsequent phases represent the average
daily rating from one session to the next. The first PMR data point represents the participant’s
social anxiety rating from that day, and the second PMR data point represents an average from
the day after the first PMR session up to and including the second PMR session. Similarly, the
first EXP data point represents the participant’s social anxiety rating from that day, and the
second EXP data point represents an average from the day after the first EXP session up to and
including the second EXP session. The POST data point represents an average from the day
following the last EXP session up to and including the day of the post-assessment. Figure 3-1
graphically displays the data for all six participants (P1 - P6).
Visual inspection of the baseline data in Figure 3-1 indicates that social anxiety was
stable or increasing for all participants except for P6. P6’s baseline ratings demonstrate a
negative trend. During the PMR phase, social anxiety remained high for P3, initially reduced but
demonstrated a positive trend for P4 and P5, and initially reduced and remained low for P6.
During the EXP phase, social anxiety gradually and substantially decreased to below BL levels
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for all participants except P6, whose social anxiety began reducing in BL and stayed low
throughout PMR and EXP. At POST, all participants’ social anxiety remained low.
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Daily social anxiety ratings for all participants across baseline (BL), progressive muscle
relaxation therapy (PMR), and exposure therapy (EXP) phases, and at the post-assessment
(POST). BL data points represent seven consecutive daily ratings. PMR1 and EXP1 represent the
rating from the day of the session. All subsequent PMR and EXP data points represent an
average of the ratings between sessions. The POST data point represents an average of the
ratings following the final day of the intervention, up to and including the day of the postassessment.
Figure 3-1: Daily Social Anxiety Ratings
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The SPAI and STAI were administered at major assessment points (BL, post-PMR, and
post-EXP). Table 3-1 presents the SPAI and STAI scores for each participant and the average of
all participants at each assessment point. (Note that P1 and P2 do not have data at post-PMR
because they were randomly assigned to receive zero sessions of PMR. They are not included in
the post-PMR mean calculation.)
SPAI scoring yields four qualitative categories: < 34 = Social Phobia Unlikely; 34 - 59 =
Possible Mild Social Phobia; 60 - 79 = Possible Social Phobia; ≥ 80 = Probable Social Phobia.
All SPAI scores were in the Probable Social Phobia range at BL (P1 = 117, P2 = 83, P3 = 137,
P4 = 105, P5 = 108, P6 = 129) and remained there at post-PMR (P3 = 115, P4 = 109, P5 = 107,
P6 = 111). At post-EXP, four participants reduced to the Possible Social Phobia range (P3 = 65,
P4 = 61, P5 = 62, P6 = 70), one participant reduced to the Possible Mild Social Phobia range (P2
= 35), and one participant reduced to the Social Phobia Unlikely range (P1 = 14). On average,
participants were in the Probable Social Phobia range at BL (M = 113.17, SD = 19.17) and postPMR (M = 110.50, SD = 3.42) and reduced to the Possible Mild Social Phobia range at post-EXP
(M = 51.17, SD = 21.92).
The STAI produces two distinct scores: State Anxiety and Trait Anxiety. For State
Anxiety, the mean score at BL was 45.67 (SD = 16.42, range 27 to 76); the mean score at postPMR was 46.00 (SD = 16.51, range 33 to 70); and the mean score at post-EXP was 27.83 (SD =
5.27, range 22 to 37). For Trait Anxiety, the mean score at BL was 55.33 (SD = 15.28, range 37
to 78); the mean score at post-PMR was 51.00 (SD = 13.63, range 41 to 71); and the mean score
at post-EXP was 38.83 (SD = 7.03, range 30 to 51). In sum, SPAI and STAI scores were all
elevated at BL and were not substantially different following PMR. However, SPAI and STAI
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scores were all reduced following EXP. The SPAI scores, in particular, represented a reliable and
clinically significant change.
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Table 3-1: Anxiety at Major Assessment Points

P1
SPAI
STAI - State
STAI - Trait
P2
SPAI
STAI - State
STAI - Trait
P3
SPAI
STAI - State
STAI - Trait
P4
SPAI
STAI - State
STAI - Trait
P5
SPAI
STAI - State
STAI - Trait
P6
SPAI
STAI - State
STAI - Trait

BL

Post-PMR

Post-EXP

117
40
68

N/A
N/A
N/A

14
28
30

83
45
50

N/A
N/A
N/A

35
22
39

137
76
78

115
70
71

65
30
51

105
39
44

109
43
44

61
25
36

108
47
55

107
33
48

62
25
36

129
27
37
BL M (SD)

111
38
41
Post-PMR M (SD)

70
37
41
Post-EXP M (SD)

Mean
SPAI
113.17 (19.17)
110.50 (3.42)
51.17 (21.92)
STAI - State
45.67 (16.42)
46.00 (16.51)
27.83 (5.27)
STAI - Trait
55.33 (15.28)
51.00 (13.63)
38.83 (7.03)
Note. P = Participant; SPAI = Social Phobia and Anxiety Inventory; STAI = State-Trait Anxiety
Inventory; BL = baseline scores; Post-PMR = scores following PMR sessions; Post-EXP =
scores following EXP sessions.
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Table 3-2 presents the clinical diagnoses for each participant at the BL and post-EXP
assessments. At BL, all participants met criteria for SAD. One participant also met diagnostic
criteria for a depressive disorder; specifically, the participant met criteria for persistent
depressive disorder with persistent major depressive episode. At the post-EXP, no participants
met criteria for any clinical disorders, except for one participant (P3) who retained the SAD
diagnosis. Despite reduced fear and anxiety related to social situations, P3 reported experiencing
continuing moderate distress and impairment related to social anxiety.

Table 3-2: Clinical Diagnoses
BL
Post-EXP
P1 SAD, Depression None
P2 SAD
None
P3 SAD
SAD
P4 SAD
None
P5 SAD
None
P6 SAD
None
Note. Diagnoses were based on ADIS-5 administration. P = Participant; BL = baseline scores;
Post-EXP = scores following EXP sessions; SAD = social anxiety disorder; Depression =
persistent depressive disorder with persistent major depressive episode.

3.1.2 Stuttering Severity
Table 3-3 presents the %WS by each participant in each of the three contexts - reading,
monologue, and conversation - at each major assessment point. Table 3-3 includes a Total for
each participant, which is an aggregate of the reading, monologue, and conversation samples. On
average, adults who stutter exhibit stuttering behaviors on about 10% of words during oral
reading (Bloodstein & Bernstein Ratner, 2008). Thus, the stuttering frequency of this sample was
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higher than the general population of people who stutter. Table 3-3 includes averages across
participants at the BL and post-EXP assessment points. The average at the post-PMR assessment
point was excluded from this table as the two participants with the highest levels of stuttering
frequency happened to be randomly assigned to receive zero PMR sessions. Thus, the average
%WS at post-PMR would have appeared dramatically lower than at BL, artificially.
P1’s %WS reduced from BL to post-EXP across all contexts. P2’s %WS increased from BL to
post-EXP across all contexts. P3’s %WS for reading remained relatively stable from BL to postPMR, but increased slightly at post-EXP. The %WS for monologue and conversation decreased
from BL to post-PMR, and then increased at post-EXP. P4’s %WS for reading decreased from
BL to post-PMR, and decreased further at post-EXP. The %WS for monologue remained
relatively stable from BL to post-PMR, but decreased at post-EXP. The %WS for conversation
reduced from BL to post-PMR, but increased slightly at post-EXP. P5’s %WS for reading
remained stable from BL to post-PMR, but increased dramatically at post-EXP. The %WS for
monologue remained relatively stable from BL to post-PMR, and increased slightly at post-EXP.
The %WS for conversation decreased from BL to post-PMR, and remained stable at post-EXP.
P6’s %WS for reading and monologue decreased from BL to post-PMR, but returned to
approximately BL levels at post-EXP. The %WS for conversation remained relatively stable
from BL to post-PMR, but increased at post-EXP. Taken together, EXP appears to have led to a
reduction in stuttering frequency for P1 and an increase in stuttering frequency for P2; the
combined interventions appear to have led to a slight reduction in stuttering frequency for P4;
and the interventions did not appear to have a significant effect on stuttering frequency for the
remaining participants.
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Table 3-3: Stuttering Frequency at Major Assessment Points

P1
Reading
Monologue
Conversation
Total
P2
Reading
Monologue
Conversation
Total
P3
Reading
Monologue
Conversation
Total
P4
Reading
Monologue
Conversation
Total
P5
Reading
Monologue
Conversation
Total
P6
Reading
Monologue
Conversation
Total
Mean
Reading
Monologue
Conversation
Total

BL

Post-PMR

Post-EXP

14.15%
25.68%
28.22%
23.04%

N/A
N/A
N/A
N/A

4.00%
19.47%
21.45%
15.53%

35.14%
20.75%
16.76%
24.12%

N/A
N/A
N/A
N/A

45.34%
27.42%
20.67%
30.64%

5.36%
4.45%
5.31%
5.03%

5.67%
1.22%
3.18%
3.27%

7.97%
7.01%
4.11%
6.19%

6.35%
4.90%
5.95%
5.69%

3.24%
5.56%
2.32%
3.78%

0.96%
1.18%
4.08%
2.06%

9.43%
13.79%
20.18%
14.53%

8.36%
13.33%
12.71%
11.55%

25.49%
17.43%
11.44%
17.29%

13.46%
11.90%
7.36%
10.67%

10.00%
8.61%
8.16%
8.90%

15.65%
9.35%
12.91%
12.65%

13.98%
13.58%
13.96%
13.85%

N/A
N/A
N/A
N/A

16.57%
13.64%
12.44%
14.06%
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Note. P = Participant; BL = baseline percentage; Post-PMR = percentage following PMR
sessions; Post-EXP = percentage following EXP sessions.

The FSS-II and the BAB were administered at major assessment points (BL, post-PMR,
and post-EXP). Table 3-4 presents the average of all participants at each assessment point. (Note
that post-PMR does not include data from P1 and P2).
For the FSS-II, the mean score at BL was 134.50 (SD = 30.31, range 108 to 190); the
mean score at post-PMR was 132.25 (SD = 45.76, range 95 to 199); and the mean score at postEXP was 111.50 (SD = 22.86, range 90 to 149). The total change is indicative of a reduction of
0.60 SDs, according to established norms for people who stutter.
For the SSC - ER, the mean score at BL was 148.67 (SD = 9.99, range 133 to 163); the
mean score at post-PMR was 151.25 (SD = 20.90, range 132 to 176); and the mean score at postEXP was 86.50 (SD = 30.92, range 40 to 122). The total change is indicative of a reduction of
2.17 SDs, according to established norms for people who stutter.
For the SSC - SD the mean score at BL was 149.17 (SD = 15.20, range 135 to 169); the
mean score at post-PMR was 148.00 (SD = 21.31, range 127 to 176); and the mean score at postEXP was 95.17 (SD = 34.72, range 43 to 138). The total change is indicative of a reduction of
1.90 SDs, according to established norms for people who stutter.
For the BCL, the mean score at BL was 35.17 (SD = 10.15, range 26 to 52); the mean
score at post-PMR was 30.50 (SD = 10.08, range 22 to 45); and the mean score at post-EXP was
22.50 (SD = 16.05, range 5 to 53). The total change is indicative of a reduction of 1.33 SDs,
according to established norms for people who stutter.
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For the BigCAT, the mean score at BL was 31.17 (SD = 2.64, range 27 to 34); the mean
score at post-PMR was 31.75 (SD = 1.71, range 30 to 34); and the mean score at post-EXP was
25.33 (SD = 7.99, range 13 to 32). The total change is indicative of a reduction of 1.11 SDs,
according to established norms for people who stutter.
Overall, the FSS-II and BAB scores remained relatively stable from BL to post-PMR,
except for the BCL, which reduced slightly; and all scores reduced markedly from post-PMR to
post-EXP.
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Table 3-4: The Affective, Behavioral, and Cognitive Experiences of Stuttering at Major
Assessment Points
BL
M (SD)
134.5 (30.31)

Post-PMR
M (SD)
132.25 (45.76)

Post-EXP
M (SD)
111.50 (22.86)

FSS-II
BAB
SSC – ER
148.67 (9.99)
151.25 (20.90)
86.50 (30.92)
SSC – SD
149.17 (15.20)
148.00 (21.31)
95.17 (34.72)
BCL
35.17 (10.15)
30.50 (10.08)
22.50 (16.05)
BigCAT
31.17 (2.64)
31.75 (1.71)
25.33 (7.99)
Note. FSS-II = Fear Survey Schedule II; BAB = Behavioral Assessment Battery; SSC – ER =
Speech Situation Checklist – Emotional Reaction; SSC – SD = Speech Situation Checklist –
Speech Disruption; BCL = Behavior Checklist; BigCAT = Communication Attitude Test for
Adults; BL = baseline scores; Post-PMR = scores following PMR sessions; Post-EXP = scores
following EXP sessions.

3.2

Secondary

Table 3-5 presents the QOLI scores for each participant at BL and post-EXP and includes
an average score across all participants. The QOLI yields four qualitative categories based on T
Score: < 37 = very low; 37 - 43 = low; 43 - 58 = average; 58 - 77 = high. At BL, three QOLI
scores were in the very low range (P1 = 24, P3 = 28, P5 = 32) and three QOLI scores were in the
average range (P2 = 53, P4 = 57, P6 = 46). At post-EXP, four participants remained in the same
category, but two participants in the very low range at BL moved up to the average range. On
average, participants were in the low range at BL (M = 40.00, SD = 13.84), and they were in the
average range at post-EXP (M = 48.33, SD = 8.62). In sum, two participants demonstrated some
improvements in quality of life, but overall changes in quality of life were not substantial.
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Table 3-5: Quality of Life
BL
Post-EXP
T-Score (Percentile)
T-Score (Percentile)
P1
24 (2%)
32 (5%)
P2
53 (61%)
46 (34%)
P3
28 (3%)
50 (49%)
P4
57 (78%)
54 (66%)
P5
32 (5%)
54 (66%)
P6
46 (34%)
54 (66%)
BL
Post-EXP
M (SD)
M (SD)
T-Score
40.00 (13.84)
48.33 (8.62)
Percentile
30.50 (32.92)
47.67 (24.57)
Note. BL = baseline scores; Post-EXP = scores following EXP sessions.

A table presenting the between-EXP-session changes on self-report of anxiety and
stuttering frequency among participants can be found in Appendix C. The table presents the
participants’ peak SUDs and peak %WS at the beginning (Session 1), middle (Session 5), and
end (Session 10) of EXP. The peak SUDs for each participant demonstrates a negative trend over
time, which represents a reduction in peak anxiety between EXP sessions. The peak %WS for
P1, P2, P4, and P5 demonstrates a negative trend over time, which represents a reduction in peak
stuttering frequency between EXP sessions. The peak %WS for P3 increased from the beginning
to the middle of EXP, and decreased slightly from the middle to the end. The peak %WS for P6
remained stable from the beginning to the middle of EXP, and increased from the middle to the
end. Overall, the peak SUDs consistently reduced over time, and the peak %WS also reduced
over time, although less consistently.
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A table presenting the between-EXP-session changes on objective observer ratings can be
found in Appendix D. The table presents the blinded observer ratings of level of anxiety (1 =
none to 5 = very severe), level of stuttering (1 = none to 5 = very severe), and overall
effectiveness of the presentation (1 = not at all to 5 = extremely). The table includes the mean
ratings across participants for each session. An examination of the mean scores reveals a steady
negative trend in level of anxiety, a lesser but still apparent negative trend in level of stuttering,
and a positive trend in overall effectiveness of the presentation. Upon examination of individual
scores, P6 stands outs as an exception, as their anxiety, stuttering, and effectiveness ratings
remain relatively stable over time.
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CHAPTER 4: DISCUSSION
This study utilized a multiple baseline design to evaluate the efficacy of an exposure
therapy protocol developed to reduce social anxiety among adults who stutter and have SAD.
This study also sought to examine whether the hypothesized reduction in social anxiety was
accompanied by a reduction in stuttering severity. The results indicated that, consistent with our
hypotheses, there were no substantial decreases in social anxiety during the baseline or PMR
phases, but five of the six participants demonstrated a gradual and substantial reduction in social
anxiety throughout the EXP phase. One participant demonstrated a reduction in social anxiety
during the baseline phase, and a small but apparent reduction in social anxiety during the PMR
phase, which persisted throughout the EXP phase, suggesting a placebo effect (Wampold,
Minami, Tierney, Baskin, & Bhati, 2005). These data suggest that the decrease in social anxiety
is likely not due to repeated assessments, self-monitoring, time, chance, regression to the mean,
or spontaneous recovery, but to EXP. The efficacy of EXP to reduce social anxiety was further
supported in measures administered at major assessment points: following PMR, social anxiety
was slightly, but not markedly improved compared to baseline, but social anxiety was
substantially improved following EXP.
Although less robust than social anxiety, state anxiety displayed a similar pattern:
minimal reduction following PMR, but moderate reduction following EXP. These findings add
to the literature that PMR alone has minimal effects in reducing social anxiety (see Rodebaugh et
al., 2004), but contradict the literature that PMR is effective in reducing general anxiety (see
Conrad & Roth, 2007). However, it is important to note two caveats. First, the role of PMR in
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this study was simply that of a psychological placebo and a small number of sessions were
provided to the participants. The very brief duration of the PMR intervention likely limited its
effectiveness. Second, the population for this study included only participants with social anxiety
disorder, and none met criteria for generalized anxiety disorder. Participants with generalized
anxiety disorder may have demonstrated a greater reduction in general anxiety following PMR.
Stuttering frequency did not demonstrate consistent change across participants. In at least
three of the participants, the interventions did not appear to influence stuttering frequency in any
consistent way. Perhaps the participants who demonstrated a reduction in anxiety, but no
significant change in stuttering frequency, represent a portion of the population whose stutter is
discrete from their anxiety.
These findings are consistent with other research reporting improvements in
psychological functioning, but no predictable change in speech fluency, following a CBT
intervention (see Helgadóttir et al., 2014; Menzies et al., 2016; Menzies et al., 2008). The
outcome of this investigation differs from several other investigations that reported speech
fluency improvement along with improved psychological functioning (see Gupta, 2016; Gupta et
al., 2016; Reddy et al., 2010); however, those studies incorporated an unknown amount of
speech therapy into their therapeutic programs, which could have accounted for the
improvements in speech fluency. In his proof-of-concept conference paper presentation, Walkom
(2016) reported psychological and fluency gains using virtual reality EXP. However, outcomes
were not rigorously assessed and detailed outcome data was not provided. In regards to speech
fluency outcomes, he simply stated, “the participants showed signs of speaking more fluently.”
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EXP appeared to most strongly influence the stuttering frequency of the two participants
with the highest levels of stuttering frequency. Perhaps anxiety plays a more significant role in
more severe cases of stuttering (Craig, Blumgart, & Tran, 2009; Iverach, Lowe, et al., 2017).
However, EXP influenced the stuttering frequency for these two participants in opposite
directions. The unique effects of EXP on stuttering frequency hint at the possibility of subgroups
among people who stutter and have SAD. While anxiety may have no role in stuttering
frequency for some people who stutter, it may play a larger role for people with higher levels of
stuttering frequency. Future research should consider this possibility.
Despite equivocal results regarding stuttering frequency, there were consistent
improvements in the affective, behavioral, and cognitive experiences of stuttering. The affective,
behavioral, and cognitive experiences of stuttering followed a similar pattern to anxiety – minor
improvements following PMR and substantial improvements following EXP. Notably,
participants reported a reduction in self-reported speech disruption. Thus, the participants
reported improvements in their speech fluency in particular situations despite no consistent
change in percentage of words stuttered. EXP may have its limits in reducing stuttering
frequency among people who stutter and have SAD, but this study provides support for the
effectiveness of EXP in improving their experience of stuttering.
The self-focused attention theory, which postulates that excessive self-focused attention
plays a role in a variety of psychopathologies, may provide an explanation for these findings (see
Ingram, 1990 for a review). Clark and Wells (1995) and Rapee and Heimberg (1997) integrated
the concept into a model for social anxiety specifically, theorizing that excessive self-focused
attention before, during, and after social interactions generates and maintains social anxiety (for

42

reviews, see Bögels & Mansell, 2004; Norton & Abbott, 2016; Spurr & Stopa, 2002).
Therapeutically, reductions in self-focused attention are associated with less anxiety and social
fear and less self-criticism (Woody, Chambless, & Glass, 1997). It is possible that in the present
study, as social anxiety reduced, so too did the focus on the self, including self-perceived speech
disruption. Future research could examine self-focused attention as a possible mechanism of
change.
Although four of the six participants showed no significant change in quality of life, two
of the three participants whose quality of life was very low at baseline made substantial gains by
the post-EXP assessment. Although this may have been due to regression to the mean, both of
these participants experienced substantial reductions in social anxiety. The EXP invention was
brief (typically lasting four to five weeks), but improved functioning may translate to meaningful
life changes that may boost overall quality of life, and participants’ quality of life may improve
over time. Longer-term follow-up may be needed to determine the full impact on quality of life.
The final aim of this study was to examine participants’ experience of EXP. Without
exception, participants reported high treatment expectancy and rationale credibility for EXP.
They provided these ratings after two sessions of EXP, arguably the most difficult sessions.
Additionally, zero participants began EXP and subsequently dropped out. Concerns that this
population cannot handle the intensive format of this therapy are not warranted. It is clear that
EXP is acceptable and efficacious for this population. Finally, the between-EXP-session
variables were examined. All participants demonstrated between-EXP-session anxiety
habituation demonstrated by their self-report and scores by observers. These data are consistent
with emotional processing theory as the mechanism by which EXP works. The peak %WS also

43

reduced between sessions, although less consistently. It is unclear whether this trend is an
accurate reflection of reduced stuttering frequency over time or whether it is due to sampling
error. Although the hypothesis was that as anxiety reduced, so too would stuttering frequency,
this was not the case in the speech samples collected at major assessment points. Future research
should include participants with more variability in stuttering severity and a larger sample size,
and those data should be analyzed using inferential statistical procedures to further examine this
issue.
Interestingly, despite the lack of substantial change in stuttering frequency, the objective
ratings of the blinded raters support a more consistent negative trend. Thus, even if the
participants had no actual change in percentage of words stuttered, there was something about
their presentations that led the raters to observe less disruption in their speech over time. It is a
limitation of this study that stuttering frequency was coded dichotomously. It is possible that
there was a change in the stuttering over time that was not captured in the dichotomous
categorization of words as either stuttered or not stuttered. For example, “st-st-st-st-st-st-stop”
and “st-stop” would both be considered a stuttered word, whereas the speech is clearly more
disrupted in the former. Unfortunately, that was beyond the scope of this study, but would be
worthy of future investigation.
The blinded raters also rated overall effectiveness of the presentations. These ratings
demonstrated a positive trend, meaning that the raters perceived the participants as more natural,
more engaging, and more comfortable during their speeches over time. A common concern
among the participants entering the study was distress and avoidance of public speaking at
school and work, which they saw as impeding their potential to succeed in these areas. No
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coaching or training about public speaking was provided during the intervention, yet the
participants made gains in this area. This finding represents a clinically significant positive
outcome.
Overall, this study supports the use of intensive EXP for people who stutter and have
SAD. Research on the use of CBT with this population is growing, but still limited. The mere
mention of EXP is scant. For example, a recent review of therapies for stuttering included few
references to CBT, and zero references to behavioral or exposure-based therapies (Humeniuk &
Tarkowski, 2016). Nonetheless, people who stutter value treatment that targets psychological
concerns, emphasizing that emotions and attitudes should be addressed in therapy for stuttering,
regardless of the aim to improve speech fluency (Humeniuk & Tarkowski, 2016; Lindsay &
Langevin, 2017). The results of the present study demonstrate the considerable gains that can
occur in relatively few sessions of EXP. As researchers continue to refine treatments for people
who stutter, the potential of EXP merits further use.
An area of research that would be worthwhile to explore is the use of virtual reality.
Virtual reality has demonstrated effectiveness in the treatment of SAD (Anderson et al., 2013;
Anderson, Rothbaum, & Hodges, 2003; Klinger et al., 2005). The EXP sessions in the present
study required several people to be available to play the role of the audience, which may not be
as feasible in community settings. Walkom (2016) reported that speaking to virtual audiences
showed promise in reducing anxiety and stuttering severity among people who stutter. Future
research should investigate this promising mode of exposure-based intervention with increased
rigor. That said, any version of CBT for people who stutter should be developed in conjunction
with speech-language pathologists, as they are the traditional service providers for people who
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stutter and can offer knowledge and insight into the unique situations of people who stutter.
Similarly, it would be beneficial to obtain feedback from actual people who stutter throughout
the development process.
This study has several strengths. The multiple baseline design controlled for threats to
internal validity. The inclusion of a psychological placebo controlled for change due to the
common factors of therapy, which increased support for the unique effectiveness of EXP. The
EXP protocol was developed specifically for a population that is comorbid for stuttering and
SAD. Inclusion was limited to people who met clinical criteria for stuttering and other
communication disorders were excluded, so this increases confidence that the effects found in
this study will generalize to the population of people who stutter. Further, the effect was
replicated across diverse individuals, which also increases generalizability. There was a
substantial decrease in anxiety levels after a relatively brief intervention. Outcome measures
included self-report, clinician-ratings, and objective observer ratings. None of the participants
dropped-out of the study after starting EXP.
This study has limitations. A single therapist administered all of the treatment and most
of the assessment; therefore, it is not possible to rule out the influence of therapist-specific
effects, demand characteristics, and observer effects. Future research should evaluate the
intervention administered by diverse therapists and incorporate a larger sample. While limiting
inclusion to people who met clinical criteria for stuttering (and no other communication
disorders) aids in the ability to generalize the finding to the population of people who stutter, this
limits the ability to generalize the findings to people with other communication disorders. An
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important future direction would be to evaluate the effectiveness of EXP for people with diverse
communication disorders.
In summary, the findings from this study provide preliminary evidence of the
effectiveness of exposure therapy in reducing anxiety and improving the affective, behavioral,
and cognitive experiences of stuttering among people who stutter and have SAD. This finding is
in line with other research in this area that supports the effectiveness of CBT with this
population. The brief nature of the intervention makes it well suited as a stand-alone
intervention, or as an adjunct to other treatments, such as speech therapy. Speech-language
pathologists and clinical psychologists should work together to develop, evaluate, and
disseminate the best care practices for this population.
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APPENDIX A: DAILY BEHAVIORAL RATINGS FORM
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APPENDIX B: BLINDED OBSERVER RATINGS FORM
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APPENDIX C: PEAK SUDS AND PEAK %WS AT THE BEGINNING,
MIDDLE, AND END OF EXPOSURE THERAPY

52

Peak SUDs and Peak %WS at the Beginning, Middle, and End of Exposure Therapy
Session 1
P1
Peak SUDS
6
Peak %WS
23.91%
P2
Peak SUDS
6
Peak %WS
19.57%
P3
Peak SUDS
6
Peak %WS
3.21%
P4
Peak SUDS
5
Peak %WS
5.35%
P5
Peak SUDS
8
Peak %WS
30.77%
P6
Peak SUDS
5
Peak %WS
9.33%
Mean
Peak SUDS
6
Peak %WS
15.36%
Note. P = Participant.

Session 5

Session 10

2
17.32%

0
16.27%

5
17.95%

4
12.50%

3
6.50%

1
4.16%

3
3.13%

2
3.59%

4
19.16%

1
20.52%

1
9.11%

1
12.40%

3
12.20%

1.5
11.57%
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APPENDIX D: BLINDED OBSERVER RATINGS OF PARTICIPANTS’
ANXIETY, STUTTERING, AND THE OVERALL EFFECTIVENESS
OF THEIR PRESENTATION
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Blinded Observer Ratings of Participants’ Anxiety, Stuttering, and the Overall Effectiveness of
Their Presentation
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
P1
Anxiety
4
2
4
3
2
2
3
3
2
2
Stuttering
5
4
3
4
3
3
3
2
3
2
Effectiveness
3
2
3
3
3
4
2
2
2
3
P2
Anxiety
3
5
4
2
2
3
4
2
1
2
Stuttering
3
3
4
3
4
3
4
3
2
3
Effectiveness
3
2
2
4
3
3
2
3
4
4
P3
Anxiety
4
4
3
3
3
3
2
2
2
2
Stuttering
3
3
2
3
3
2
2
2
3
2
Effectiveness
2
2
3
2
2
2
3
4
3
3
P4
Anxiety
3
3
3
2
1
1
2
2
1
1
Stuttering
3
4
2
1
1
2
2
2
2
1
Effectiveness
2
3
3
4
4
4
4
4
4
5
P5
Anxiety
5
4
4
3
3
3
3
3
2
2
Stuttering
5
3
4
4
4
3
3
4
3
3
Effectiveness
2
2
2
2
3
3
3
3
3
4
P6
Anxiety
2
2
3
2
3
2
2
2
2
2
Stuttering
2
2
2
2
4
2
3
2
3
2
Effectiveness
4
3
2
3
2
4
3
3
3
3
Mean
Anxiety
3.50 3.33 3.50 2.50 2.33 2.33 2.67 2.33 1.67 1.83
Stuttering
3.50 3.17 2.83 2.83 3.17 2.50 2.83 2.50 2.67 2.17
Effectiveness
2.67 2.33 2.50 3.00 2.83 3.33 2.83 3.17 3.17 3.67
Note. P = Participant; S = Session
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APPENDIX E: APPROVAL OF HUMAN RESEARCH
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